文献速递牙周病

牙周治疗对稳定性冠心病患者心血管风险生物标志物的随机对照试验:3个月初步结果

Randomized controlled trial of the effect of periodontal treatment on cardiovascular risk biomarkers in patients with stable coronary artery disease: Preliminary findings of 3 months.
PubMed 文献 · J Clin Periodontol · 2019-03-06

这项单盲、平行设计随机对照试验纳入稳定性冠心病伴牙周炎患者,比较非手术牙周治疗与一次菌斑清除对心血管血液生物标志物的影响。3个月后牙周治疗组牙周参数显著优于对照组,但两组血液标志物整体无显著差异;事后亚组分析显示基线CRP<3 mg/L者对照组CRP显著升高而治疗组不变,基线CRP≥3 mg/L者仅治疗组CRP显著降低。结论为牙周治疗可降低高CRP心血管患者的CRP、IL-6和IL-8水平。

要点

  • 牙周治疗3个月改善牙周参数,但整体未显著改变血液炎症标志物。
  • 基线CRP<3 mg/L者,对照组CRP显著升高,治疗组保持不变。
  • 基线CRP≥3 mg/L者,仅牙周治疗组CRP显著降低。

核心结论

  • 牙周治疗可降低高CRP水平心血管患者的CRP、IL-6和IL-8水平。

研究设计与样本

  • 单盲、平行设计随机对照试验,纳入稳定性冠心病伴牙周炎患者,分析82例(74.4%女性,平均年龄59.6岁)。
  • 试验组接受非手术牙周治疗,对照组接受一次菌斑清除,基线和3个月时检测血浆CRP、糖化血红蛋白、血脂和细胞因子。

主要发现

  • 3个月后试验组牙周参数显著优于对照组,但两组间血液标志物整体无显著差异。
  • 基线CRP<3 mg/L亚组中,对照组CRP从1.44 ± 0.82 mg/L升至4.35 ± 7.85 mg/L(p = 0.01),试验组从1.40 ± 0.96 mg/L至1.33 ± 1.26 mg/L(p = 0.85),3个月时组间差异显著。
  • 基线CRP≥3 mg/L亚组中,仅试验组CRP显著降低,从11.3 ± 12.8 mg/L降至5.7 ± 4.1 mg/L(p = 0.04)。
  • 3个月时试验组IL-6和IL-8水平显著低于对照组。

临床怎么用

  • 对稳定性冠心病伴牙周炎患者,牙周治疗可能有助于降低高CRP者的全身炎症水平。
  • 基线CRP水平可能影响牙周治疗对心血管风险标志物的效应,需个体化评估。

局限性

  • 本文为3个月初步结果,长期效应尚不明确。
  • 亚组分析为事后分析,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To assess the effect of periodontal therapy (PT) on cardiovascular blood biomarkers. MATERIALS AND METHODS: This single-blind, parallel-design, randomized controlled trial included patients with stable coronary artery disease and periodontitis. The test group (TG) received non-surgical PT, whereas the control group (CG) received one session of plaque removal. Plasma levels of C-reactive protein (CRP), glycated haemoglobin, lipids and cytokines (IL-1β, IL-6, IL-8, IL-10, IFN-γ and TNF-α) were measured at baseline and after 3 months. RESULTS: Eighty-two patients (74.4% women, mean age 59.6 years) were analysed. TG had significantly better periodontal parameters than CG after 3 months, but no significant differences in blood markers were observed between them. In a post hoc subgroup analysis in patients with baseline CRP <3 mg/L, a significant increase in CRP was observed in CG (1.44 ± 0.82 mg/L to 4.35 ± 7.85 mg/L, p = 0.01), whereas CRP remained unchanged in TG (1.40 ± 0.96 mg/L to 1.33 ± 1.26 mg/L, p = 0.85), resulting in a significant difference between groups at 3 months. In patients with CRP ≥3 mg/L, a significant reduction in CRP was observed only in TG (11.3 ± 12.8 mg/L to 5.7 ± 4.1 mg/L, p = 0.04). Levels of IL-6 and IL-8 were significantly lower in TG than CG at 3 months. CONCLUSIONS: PT leads to lower levels of CRP, IL-6 and IL-8 in cardiovascular patients with high CRP levels.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Montenegro MM, Ribeiro IWJ, Kampits C, et al. Randomized controlled trial of the effect of periodontal treatment on cardiovascular risk biomarkers in patients with stable coronary artery disease: Preliminary findings of 3 months. J Clin Periodontol. 2019. PMID: 30761568. doi:10.1111/jcpe.13085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。